BUCHAREST (Romania), June 20 (SeeNews) - Romanian state-controlled drug maker Antibiotice [BSE:ATB] plans to invest 10 million euro ($13.6 million) by the end of 2016 in a new production line for salves and suppositories, local media reported on Friday.